276 related articles for article (PubMed ID: 20299168)
1. [Interstitial pneumonia related to mesalamine].
Lamsiah T; Moudden K; Baaj M; Hadri L
Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
[TBL] [Abstract][Full Text] [Related]
2. Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
Moss AC; Cheifetz AS; Peppercorn MA
Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):290-3. PubMed ID: 16673009
[TBL] [Abstract][Full Text] [Related]
3. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
[TBL] [Abstract][Full Text] [Related]
4. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
MMW Fortschr Med; 2004 Jun; 146(24):53. PubMed ID: 15366501
[No Abstract] [Full Text] [Related]
5. Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.
Connolly MP; Poole CD; Currie CJ; Marteau P; Nielsen SK
Digestion; 2009; 80(4):241-6. PubMed ID: 19828955
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
7. Acute interstitial nephritis due to mesalazine.
Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
[TBL] [Abstract][Full Text] [Related]
8. [A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].
Shimizu T; Hayashi M; Shimizu N; Kinebuchi S; Toyama J
Nihon Kokyuki Gakkai Zasshi; 2009 Jun; 47(6):543-7. PubMed ID: 19601534
[TBL] [Abstract][Full Text] [Related]
9. [Early renal failure caused by mesalazine].
Musil D
Vnitr Lek; 2000 Oct; 46(10):728-31. PubMed ID: 11344635
[TBL] [Abstract][Full Text] [Related]
10. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
Rufle W; Frühmorgen P; Huber W; Kimmig JM
Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
[TBL] [Abstract][Full Text] [Related]
11. [A case of lung injury induced by long-term administration of mesalazine].
Shindoh Y; Horaguchi R; Hayashi K; Suda Y; Iijima H; Shindoh C
Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):861-6. PubMed ID: 22171492
[TBL] [Abstract][Full Text] [Related]
12. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Uittenbogaart SB; Klemt-Kropp M
Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P
Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173
[TBL] [Abstract][Full Text] [Related]
15. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
Raedler A; Behrens C; Bias P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1353-63. PubMed ID: 15606398
[TBL] [Abstract][Full Text] [Related]
16. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
Actis GC; Ottobrelli A; Baldi S; Scappaticci E; Modena V; Fusaro E; Mengozzi G; Rizzetto M
Mt Sinai J Med; 2005 Mar; 72(2):136-40. PubMed ID: 15770345
[TBL] [Abstract][Full Text] [Related]
17. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
Marshall JK; Irvine EJ
Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
Miner PB; Wedel MK; Xia S; Baker BF
Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
[TBL] [Abstract][Full Text] [Related]
19. [Acute pericarditis associated with oral or topical mesalazine therapy in patients with ulcerative colitis].
Calafat M; Mañosa M; Cabré E; Domènech E
Gastroenterol Hepatol; 2014 Apr; 37(4):254-5. PubMed ID: 24333139
[No Abstract] [Full Text] [Related]
20. Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.
Kruis W; Jonaitis L; Pokrotnieks J; Mikhailova TL; Horynski M; Bátovský M; Lozynsky YS; Zakharash Y; Rácz I; Kull K; Vcev A; Faszczyk M; Dilger K; Greinwald R; Mueller R;
Aliment Pharmacol Ther; 2011 Feb; 33(3):313-22. PubMed ID: 21138455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]